267 related articles for article (PubMed ID: 16100290)
1. Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia.
van der Sluijs KF; van Elden LJ; Nijhuis M; Schuurman R; Florquin S; Shimizu T; Ishii S; Jansen HM; Lutter R; van der Poll T
Am J Physiol Lung Cell Mol Physiol; 2006 Jan; 290(1):L194-9. PubMed ID: 16100290
[TBL] [Abstract][Full Text] [Related]
2. Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice.
Rijneveld AW; Weijer S; Florquin S; Speelman P; Shimizu T; Ishii S; van der Poll T
J Infect Dis; 2004 Feb; 189(4):711-6. PubMed ID: 14767826
[TBL] [Abstract][Full Text] [Related]
3. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor.
McCullers JA; Rehg JE
J Infect Dis; 2002 Aug; 186(3):341-50. PubMed ID: 12134230
[TBL] [Abstract][Full Text] [Related]
4. The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza.
McCullers JA; Iverson AR; McKeon R; Murray PJ
Scand J Infect Dis; 2008; 40(1):11-7. PubMed ID: 17852951
[TBL] [Abstract][Full Text] [Related]
5. Expression and DNA microarray analysis of a platelet activating factor-related molecule in severe pneumonia in mice due to influenza virus and bacterial co-infection.
Seki M; Kosai K; Hara A; Imamura Y; Nakamura S; Kurihara S; Izumikawa K; Kakeya H; Yamamoto Y; Yanagihara K; Miyazaki Y; Mukae H; Tashiro T; Kohno S
Jpn J Infect Dis; 2009 Jan; 62(1):6-10. PubMed ID: 19168951
[TBL] [Abstract][Full Text] [Related]
6. Exposure to welding fumes and lower airway infection with Streptococcus pneumoniae.
Suri R; Periselneris J; Lanone S; Zeidler-Erdely PC; Melton G; Palmer KT; Andujar P; Antonini JM; Cohignac V; Erdely A; Jose RJ; Mudway I; Brown J; Grigg J
J Allergy Clin Immunol; 2016 Feb; 137(2):527-534.e7. PubMed ID: 26277596
[TBL] [Abstract][Full Text] [Related]
7. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection.
van der Sluijs KF; van Elden LJ; Nijhuis M; Schuurman R; Pater JM; Florquin S; Goldman M; Jansen HM; Lutter R; van der Poll T
J Immunol; 2004 Jun; 172(12):7603-9. PubMed ID: 15187140
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2 does not contribute to host response during postinfluenza pneumococcal pneumonia.
Dessing MC; van der Sluijs KF; Florquin S; Akira S; van der Poll T
Am J Respir Cell Mol Biol; 2007 May; 36(5):609-14. PubMed ID: 17170383
[TBL] [Abstract][Full Text] [Related]
9. Limited anti-inflammatory role for interleukin-1 receptor like 1 (ST2) in the host response to murine postinfluenza pneumococcal pneumonia.
Blok DC; van der Sluijs KF; Florquin S; de Boer OJ; van 't Veer C; de Vos AF; van der Poll T
PLoS One; 2013; 8(3):e58191. PubMed ID: 23483993
[TBL] [Abstract][Full Text] [Related]
10. Prevotella intermedia induces severe bacteremic pneumococcal pneumonia in mice with upregulated platelet-activating factor receptor expression.
Nagaoka K; Yanagihara K; Morinaga Y; Nakamura S; Harada T; Hasegawa H; Izumikawa K; Ishimatsu Y; Kakeya H; Nishimura M; Kohno S
Infect Immun; 2014 Feb; 82(2):587-93. PubMed ID: 24478074
[TBL] [Abstract][Full Text] [Related]
11. Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia.
van der Sluijs KF; Nijhuis M; Levels JH; Florquin S; Mellor AL; Jansen HM; van der Poll T; Lutter R
J Infect Dis; 2006 Jan; 193(2):214-22. PubMed ID: 16362885
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor receptor contributes to host defense against Pseudomonas aeruginosa pneumonia but is not essential for the accompanying inflammatory and procoagulant response.
van Zoelen MA; Florquin S; Meijers JC; de Beer R; de Vos AF; de Boer OJ; van der Poll T
J Immunol; 2008 Mar; 180(5):3357-65. PubMed ID: 18292561
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-35 is upregulated in response to influenza virus infection and secondary bacterial pneumonia.
Chen Y; Wang CJ; Lin SH; Zhang M; Li SY; Xu F
Cytokine; 2016 May; 81():23-7. PubMed ID: 26844658
[TBL] [Abstract][Full Text] [Related]
14. CCAAT/enhancer-binding protein δ facilitates bacterial dissemination during pneumococcal pneumonia in a platelet-activating factor receptor-dependent manner.
Duitman J; Schouten M; Groot AP; Borensztajn KS; Daalhuisen JB; Florquin S; van der Poll T; Spek CA
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):9113-8. PubMed ID: 22615380
[TBL] [Abstract][Full Text] [Related]
15. A1 adenosine receptor signaling reduces Streptococcus pneumoniae adherence to pulmonary epithelial cells by targeting expression of platelet-activating factor receptor.
Bhalla M; Hui Yeoh J; Lamneck C; Herring SE; Tchalla EYI; Heinzinger LR; Leong JM; Bou Ghanem EN
Cell Microbiol; 2020 Feb; 22(2):e13141. PubMed ID: 31709673
[TBL] [Abstract][Full Text] [Related]
16. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia.
Rijneveld AW; Levi M; Florquin S; Speelman P; Carmeliet P; van Der Poll T
J Immunol; 2002 Apr; 168(7):3507-11. PubMed ID: 11907112
[TBL] [Abstract][Full Text] [Related]
17. An antagonist of the platelet-activating factor receptor inhibits adherence of both nontypeable Haemophilus influenzae and Streptococcus pneumoniae to cultured human bronchial epithelial cells exposed to cigarette smoke.
Shukla SD; Fairbairn RL; Gell DA; Latham RD; Sohal SS; Walters EH; O'Toole RF
Int J Chron Obstruct Pulmon Dis; 2016; 11():1647-55. PubMed ID: 27524890
[TBL] [Abstract][Full Text] [Related]
18. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia.
van Zoelen MA; Schouten M; de Vos AF; Florquin S; Meijers JC; Nawroth PP; Bierhaus A; van der Poll T
J Immunol; 2009 Apr; 182(7):4349-56. PubMed ID: 19299735
[TBL] [Abstract][Full Text] [Related]
19. IL-18 improves the early antimicrobial host response to pneumococcal pneumonia.
Lauw FN; Branger J; Florquin S; Speelman P; van Deventer SJ; Akira S; van der Poll T
J Immunol; 2002 Jan; 168(1):372-8. PubMed ID: 11751983
[TBL] [Abstract][Full Text] [Related]
20. Activation of IL-27 signalling promotes development of postinfluenza pneumococcal pneumonia.
Cao J; Wang D; Xu F; Gong Y; Wang H; Song Z; Li D; Zhang H; Li D; Zhang L; Xia Y; Xu H; Lai X; Lin S; Zhang X; Ren G; Dai Y; Yin Y
EMBO Mol Med; 2014 Jan; 6(1):120-40. PubMed ID: 24408967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
